These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 39013971)

  • 1. Predicting pathological complete response after neoadjuvant chemotherapy in breast cancer by clinicopathological indicators and ultrasound parameters using a nomogram.
    Zhang T; Liu Y; Tian T
    Sci Rep; 2024 Jul; 14(1):16348. PubMed ID: 39013971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study.
    Qian B; Yang J; Zhou J; Hu L; Zhang S; Ren M; Qu X
    Front Endocrinol (Lausanne); 2022; 13():955250. PubMed ID: 36060977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nomogram based on platelet-to-lymphocyte ratio for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy.
    Ma R; Wei W; Ye H; Dang C; Li K; Yuan D
    BMC Cancer; 2023 Mar; 23(1):245. PubMed ID: 36918796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory indicators predict axillary nodal pathologic complete response after neoadjuvant therapy in breast cancer.
    Chen P; Zhao T; Bi Z; Zhang ZP; Xie L; Liu YB; Song XG; Song XR; Wang CJ; Wang YS
    Future Oncol; 2021 Jul; 17(19):2449-2460. PubMed ID: 33878939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and Validation of a Serum Albumin-to-Alkaline Phosphatase Ratio-Based Nomogram for Predicting Pathological Complete Response in Breast Cancer.
    Qu F; Li Z; Lai S; Zhong X; Fu X; Huang X; Li Q; Liu S; Li H
    Front Oncol; 2021; 11():681905. PubMed ID: 34692474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a retrospective study.
    Tang L; Shu X; Tu G
    World J Surg Oncol; 2022 Jan; 20(1):27. PubMed ID: 35093083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinicopathological-imaging nomogram for the prediction of pathological complete response in breast cancer cases administered neoadjuvant therapy.
    Yang W; Yang Y; Zhang C; Yin Q; Zhang N
    Magn Reson Imaging; 2024 Sep; 111():120-130. PubMed ID: 38703971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Nomogram for Individually Predicting Pathologic Complete Remission After Preoperative Chemotherapy in Chinese Breast Cancer: A Population-Based Study.
    Hou N; Xiao J; Wang Z; Wu Y; Hou G; Guo L; Zhang J; Ling R
    Clin Breast Cancer; 2020 Dec; 20(6):e682-e694. PubMed ID: 32713825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer.
    Jin X; Jiang YZ; Chen S; Yu KD; Ma D; Sun W; Shao ZM; Di GH
    BMC Cancer; 2016 Aug; 16():606. PubMed ID: 27495967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer.
    Rouzier R; Pusztai L; Garbay JR; Delaloge S; Hunt KK; Hortobagyi GN; Berry D; Kuerer HM
    Cancer; 2006 Oct; 107(7):1459-66. PubMed ID: 16948128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound-based prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients.
    Baumgartner A; Tausch C; Hosch S; Papassotiropoulos B; Varga Z; Rageth C; Baege A
    Breast; 2018 Jun; 39():19-23. PubMed ID: 29518677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of neoadjuvant chemotherapy pathological complete response for breast cancer based on radiomics nomogram of intratumoral and derived tissue.
    Zheng G; Hou J; Shu Z; Peng J; Han L; Yuan Z; He X; Gong X
    BMC Med Imaging; 2024 Jan; 24(1):22. PubMed ID: 38245712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer.
    Li Y; Chen Y; Zhao R; Ji Y; Li J; Zhang Y; Lu H
    Eur Radiol; 2022 Mar; 32(3):1676-1687. PubMed ID: 34767068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation.
    Zheng Q; Yan H; He Y; Wang J; Zhang N; Huo L; Liu Y; Wang L; Xu L; Fan Z
    Cancer; 2024 Apr; 130(S8):1513-1523. PubMed ID: 38427584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Data on Pathological Response and Survival Outcomes After Neoadjuvant Chemotherapy in HER2-Low Breast Cancer Patients.
    Guan D; Shi Q; Zheng Y; Zheng C; Meng X
    Clin Breast Cancer; 2024 Jul; 24(5):463-472.e2. PubMed ID: 38744585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the Association Between Type 2 Diabetes Mellitus and Pathological Responses Among Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Javed S; Mohamed Noor DA; Md Hanafiah NH; Javed U; Mustafa T; Rehman AU; Harun SN
    J Surg Res; 2024 Jul; 299():85-93. PubMed ID: 38718688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram based on quantitative dynamic contrast-enhanced magnetic resonance imaging, apparent diffusion coefficient, and clinicopathological features for early prediction of pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy.
    He M; Su J; Ruan H; Song Y; Ma M; Xue F
    Quant Imaging Med Surg; 2023 Jul; 13(7):4089-4102. PubMed ID: 37456283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The accuracy of MRI in detecting pathological complete response following neoadjuvant chemotherapy in different breast cancer subtypes.
    Kuzmova M; Cullinane C; Rutherford C; McCartan D; Rothwell J; Evoy D; Geraghty J; Prichard RS
    Surg Oncol; 2023 Dec; 51():102011. PubMed ID: 37931546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
    Guan D; Jie Q; Wu Y; Xu Y; Hong W; Meng X
    World J Surg Oncol; 2022 Sep; 20(1):326. PubMed ID: 36175898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Multiparametric MRI Radiomics-Based Nomogram in Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Two-Center study.
    Wang X; Hua H; Han J; Zhong X; Liu J; Chen J
    Clin Breast Cancer; 2023 Aug; 23(6):e331-e344. PubMed ID: 37321954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.